| Ticker Details |
|
89bio, Inc. Common Stock
|
| IPO Date: |
November 19, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$2.2B |
| Activated in VL: |
False |
| Average Daily Range |
| Avg Daily Range: |
$0.37 | 3.34%
|
| Avg Daily Range (30 D): |
$0.02 | 0.16%
|
| Avg Daily Range (90 D): |
$0.14 | 1.49%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.01M |
| Avg Daily Volume (30 D): |
2.97M |
| Avg Daily Volume (90 D): |
3.43M |
| Trade Size |
| Avg Trade Size (Sh.): |
112 |
| Avg Trade Size (Sh.) (30 D): |
372 |
| Avg Trade Size (Sh.) (90 D): |
227 |
| Institutional Trades |
| Total Institutional Trades: |
1,741 |
| Avg Institutional Trade: |
$2.64M |
| Avg Institutional Trade (30 D): |
$6.66M |
| Avg Institutional Trade (90 D): |
$3.86M |
| Avg Institutional Trade Volume: |
.21M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.01M |
| Avg Closing Trade (30 D): |
$19.72M |
| Avg Closing Trade (90 D): |
$6.93M |
| Avg Closing Volume: |
255.76K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q3 2024 |
|
Basic EPS
|
$-.71
|
$-.49
|
$-1.39
|
|
Diluted EPS
|
$-.71
|
$-.49
|
$-1.39
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-111.5M
|
$-71.28M
|
$-149.07M
|
|
Operating Income / Loss
|
$-115.82M
|
$-75.91M
|
$-151.94M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-186.32M
|
$189.34M
|
$-120.81M
|
|
PE Ratio
|
|
|
|
|
|
|